NCT01807117 - PET-MRI in Diagnosing Patients With Colon or Rectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

March 5, 2014

Study Completion Date

March 5, 2014

Conditions

Recurrent Colon CancerRecurrent Rectal CancerStage IIA Colon CancerStage IIA Rectal CancerStage IIB Colon CancerStage IIB Rectal CancerStage IIC Colon CancerStage IIC Rectal CancerStage IIIA Colon CancerStage IIIA Rectal CancerStage IIIB Colon CancerStage IIIB Rectal CancerStage IIIC Colon CancerStage IIIC Rectal CancerStage IVA Colon CancerStage IVA Rectal CancerStage IVB Colon CancerStage IVB Rectal Cancer

Interventions

PROCEDURE

positron emission tomography

Undergo fludeoxyglucose F 18 PET-CT and PET-MRI

PROCEDURE

computed tomography

Undergo fludeoxyglucose F 18 PET-CT and PET-MRI

PROCEDURE

magnetic resonance imaging

Undergo fludeoxyglucose F 18 PET-CT and PET-MRI

RADIATION

fludeoxyglucose F 18

Undergo fludeoxyglucose F 18 PET-CT and PET-MRI

Trial Locations (1)

44106-5065

University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors

lead

Case Comprehensive Cancer Center

OTHER